A patient in the UK has received a new therapy for Huntington’s disease, which experts hope could slow progression of the ...

The findings suggest that beta-blockers and other drugs that help restore balance to the autonomic nervous system may have ...

Research indicates β-blockers may reduce the risk of motor diagnosis and slow symptom progression in Huntington's disease, ...

Novartis is paying $1 billion upfront for global rights to PTC Therapeutics’ midphase Huntington's disease program, helping ...

Swiss drugmaker Novartis will pay up to $2.9 billion for PTC Therapeutics' promising experimental drug for a neurological ...

Novartis will make an upfront payment of $1.0 billion to PTCT and the latter will also be eligible for up to $1.9 billion in ...

Common symptoms of Huntington's include uncontrolled movements like jerking and twitching, loss of coordination, difficulty ...

Monday’s agreement comes days after PTC discontinued the development of another asset, utreloxastat, due to disappointing ...

At the center of a new licensing deal is an experimental medicine, PTC518, which is currently being tested in a roughly ...

After years of setbacks, biotechs are advancing treatments for Huntington’s disease, offering new hope as clinical studies ...

The Wicked Witch of the West and I have something in common: We both use our fatal flaws to our advantage—for her, her green ...

A common heart drug may slow the progression of Huntington's disease (HD), according to a new study by University of Iowa ...